Invention Grant
- Patent Title: Use of resected liver serum for whole liver-engineering
-
Application No.: US17665955Application Date: 2022-02-07
-
Publication No.: US12076461B2Publication Date: 2024-09-03
- Inventor: Jeffrey Ross , Anne Young , Allie Haarstad , Scott Nyberg
- Applicant: Miromatrix Medical Inc. , Mayo Foundation for Medical Education and Research
- Applicant Address: US MN Eden Prairie
- Assignee: Miromatrix Medical Inc.,Mayo Foundation for Medical Education & Research, Mayo Medical Ventures
- Current Assignee: Miromatrix Medical Inc.,Mayo Foundation for Medical Education & Research, Mayo Medical Ventures
- Current Assignee Address: US MN Eden Prairie; US MN Rochester
- Agency: Greenberg Traurig, LLP
- Main IPC: A61L27/36
- IPC: A61L27/36 ; A61L27/24 ; A61L27/38 ; C12N5/071
Abstract:
The disclosure provides a method of using blood or fractions thereof, e.g., serum, obtained from a mammal subjected to liver surgery, for example, obtained following a partial hepatectomy, to increase the engraftment, proliferation and/or functionality of cells on a biocompatible scaffold.
Public/Granted literature
- US20220323645A1 Use of Resected Liver Serum for Whole Liver-Engineering Public/Granted day:2022-10-13
Information query
